Close
MIDAS
MIDAS Network Member

Paper Information

Title

Reply to: Comment on: "Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia".

Abstract

No abstract available.

Journal

Pediatric blood & cancer

Citation

McCormick M, Friehling E, Smith K. (2022). Reply to: Comment on: "Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia". Pediatric blood & cancer

MIDAS Authors